The researchers found that while more cases than controls received at least 6 courses of antibiotics (17.9 versus 13.8%), the association between antibiotic use and risk of diabetes was progressively reduced when clinical and lifestyle factors were accounted for.
Adherence better for sulfonylureas and thiazolidinediones compared with metformin
Multiple regression analyses revealed that fat intake, especially saturated fat intake, was significantly correlated with ΔHbA1c.
To determine the risk of T2DM, researchers compared adults with psoriasis (n=8124), grouping them by affected BSA, to those without psoriasis (n=76,599); patients were followed for ~4 years.
Among all study drugs, the highest rate was seen with glyburide.
The data showed diabetes following pancreatic disease was more common than type 1 diabetes (2.59 [95% CI: 2.38-2.81] per 100,000 person-years vs. 1.64 [95% CI: 1.47-1.82]; P<0.001). These cases of diabetes following pancreatic disease (n=559) were primarily classified by clinicians as type 2 diabetes.
Researchers assessed incident diabetes by annual 75g oral glucose tolerance testing and semiannual fasting glucose among 3,234 participants enrolled in the Diabetes Prevention Program Outcomes Study.
In clinical trials, treatment with Bydureon BCise resulted in average HbA1c reductions of up to 1.4% and average weight loss of up to 3.1 pounds when used as monotherapy or as an add-on to metormin, a sulfonylurea, a thiazolidinedione, or any combination of two of these agents, at 28 weeks.
Researchers found an approximate 1% decrease in HbA1c with the addition of a sulfonylurea or metformin to insulin.
The Humalog Junior KwikPen is lighter and shorter than other half-unit insulin pens.
